Role of the ubiquitin-proteasome system in the regulation of P2Y13 receptor expression: impact on hepatic HDL uptake
Autor: | Nicole Malet, Stéphanie Gayral, Camille Malaval, Michel Nauze, Laurent O. Martinez, Véronique Pons, Céline Galés, Nizar Serhan, Muriel Laffargue |
---|---|
Přispěvatelé: | Simon, Marie Francoise, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM) |
Jazyk: | angličtina |
Rok vydání: | 2014 |
Předmět: |
Receptor expression
MESH: Amino Acid Sequence Endoplasmic Reticulum MESH: Mice Knockout MESH: Lipoproteins HDL MESH: Receptors Purinergic P2Y12 Mice chemistry.chemical_compound Ubiquitin MESH: Animals Receptor Mice Knockout MESH: Proteasome Endopeptidase Complex Reverse cholesterol transport Hep G2 Cells Endocytosis Receptors Purinergic P2Y12 Liver MESH: HEK293 Cells MESH: Endocytosis Molecular Medicine Lipoproteins HDL Proteasome Endopeptidase Complex medicine.medical_specialty MESH: Ubiquitin Recombinant Fusion Proteins MESH: Hep G2 Cells [SDV.BC]Life Sciences [q-bio]/Cellular Biology Biology Cellular and Molecular Neuroscience MESH: Mice Inbred C57BL MESH: Endoplasmic Reticulum Internal medicine medicine MESH: Recombinant Fusion Proteins Animals Humans MESH: Receptors Purinergic P2 Amino Acid Sequence Molecular Biology [SDV.BC] Life Sciences [q-bio]/Cellular Biology MESH: Mice Pharmacology MESH: Humans Receptors Purinergic P2 Cholesterol Endoplasmic reticulum Cell Membrane Ubiquitination Cell Biology Mice Inbred C57BL HEK293 Cells Endocrinology chemistry Proteasome MESH: HeLa Cells biology.protein MESH: Ubiquitination HeLa Cells MESH: Liver MESH: Cell Membrane |
Zdroj: | Cellular and Molecular Life Sciences Cellular and Molecular Life Sciences, 2014, 71 (9), pp.1775-88. ⟨10.1007/s00018-013-1471-5⟩ Cellular and Molecular Life Sciences, Springer Verlag, 2014, 71 (9), pp.1775-88. ⟨10.1007/s00018-013-1471-5⟩ |
ISSN: | 1420-682X 1420-9071 |
DOI: | 10.1007/s00018-013-1471-5⟩ |
Popis: | International audience; The protective effect of high density lipoproteins (HDL) against atherosclerosis is mainly attributed to their capacity to transport excess cholesterol from peripheral tissues back to the liver for further elimination into the bile, a process called reverse cholesterol transport (RCT). Recently, the importance of the P2Y13 receptor (P2Y13-R) was highlighted in HDL metabolism since HDL uptake by the liver was decreased in P2Y13-R deficient mice, which translated into impaired RCT. Here, we investigated for the first time the molecular mechanisms regulating cell surface expression of P2Y13-R. When transiently expressed, P2Y13-R was mainly detected in the endoplasmic reticulum (ER) and strongly subjected to proteasome degradation while its homologous P2Y12 receptor (P2Y12-R) was efficiently targeted to the plasma membrane. We observed an inverse correlation between cell surface expression and ubiquitination level of P2Y13-R in the ER, suggesting a close link between ubiquitination of P2Y13-R and its efficient targeting to the plasma membrane. The C-terminus tail exchange between P2Y13-R and P2Y12-R strongly restored plasma membrane expression of P2Y13-R, suggesting the involvement of the intra-cytoplasmic tail of P2Y13-R in expression defect. Accordingly, proteasomal inhibition increased plasma membrane expression of functionally active P2Y13-R in hepatocytes, and consequently stimulated P2Y13-R-mediated HDL endocytosis. Importantly, proteasomal inhibition strongly potentiated HDL hepatic uptake (>200 %) in wild-type but not in P2Y13-R-deficient mice, thus reinforcing the role of P2Y13-R expression in regulating HDL metabolism. Therefore, specific inhibition of the ubiquitin-proteasome system might be a novel powerful HDL therapy to enhance P2Y13-R expression and consequently promote the overall RCT. |
Databáze: | OpenAIRE |
Externí odkaz: |